|
From the Division of Cardiology (Humphries) and the Division of Endocrinology and Metabolism (Gill), Department of Medicine, St. Paul's Hospital, University of British Columbia and Centre for Health Evaluation & Outcome Sciences, Vancouver, BC.
Correspondence to: Dr. Sabrina Gill, Division of Endocrinology and Metabolism, St. Paul's Hospital, Rm. 467, Comox Building, 1081 Burrard St., Vancouver BC V6Z 1Y6; fax 604 806-8594; sgill{at}providencehealth.bc.ca
Abstract
UNTIL RECENTLY, OBSERVATIONAL STUDIES suggested a decreased risk of cardiovascular disease, osteoporotic fractures, cognitive decline and colon cancer with the use of hormone replacement therapy (HRT). Recent randomized controlled trials have failed to show a protective effect of HRT in reducing the risk of coronary artery disease and instead have revealed an increased risk of heart disease, stroke, invasive breast cancer and venous thromboembolism, but a decreased risk of colorectal cancer and osteoporotic fractures. In this article we review the current evidence of the risks and benefits of HRT.
Related Article
This article has been cited by other articles:
![]() |
K.-M. Suzuki, Y. Isohama, H. Maruyama, Y. Yamada, Y. Narita, S. Ohta, Y. Araki, T. Miyata, and S. Mishima Estrogenic Activities of Fatty Acids and a Sterol Isolated from Royal Jelly Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 295 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wooltorton Combination hormone replacement therapy and dementia Can. Med. Assoc. J., July 22, 2003; 169(2): 133 - 133. [Full Text] [PDF] |
||||
Read all eLetters